nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—SLC36A1—brainstem—multiple sclerosis	0.0159	0.0809	CbGeAlD
Vigabatrin—ABAT—brainstem—multiple sclerosis	0.0158	0.0804	CbGeAlD
Vigabatrin—ABAT—retina—multiple sclerosis	0.0152	0.0776	CbGeAlD
Vigabatrin—GABBR1—medulla oblongata—multiple sclerosis	0.0141	0.0718	CbGeAlD
Vigabatrin—GABBR1—midbrain—multiple sclerosis	0.0129	0.0657	CbGeAlD
Vigabatrin—GABBR1—spinal cord—multiple sclerosis	0.0126	0.0641	CbGeAlD
Vigabatrin—SLC36A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.0124	0.111	CbGpPWpGaD
Vigabatrin—ABAT—medulla oblongata—multiple sclerosis	0.011	0.0561	CbGeAlD
Vigabatrin—ABAT—midbrain—multiple sclerosis	0.01	0.0513	CbGeAlD
Vigabatrin—GABBR1—cerebellum—multiple sclerosis	0.00996	0.0508	CbGeAlD
Vigabatrin—ABAT—spinal cord—multiple sclerosis	0.0098	0.05	CbGeAlD
Vigabatrin—GABBR1—Potassium Channels—KCNA3—multiple sclerosis	0.00929	0.0834	CbGpPWpGaD
Vigabatrin—SLC36A1—nervous system—multiple sclerosis	0.00831	0.0424	CbGeAlD
Vigabatrin—ABAT—nervous system—multiple sclerosis	0.00826	0.0421	CbGeAlD
Vigabatrin—GABBR1—brain—multiple sclerosis	0.00809	0.0413	CbGeAlD
Vigabatrin—SLC36A1—central nervous system—multiple sclerosis	0.008	0.0408	CbGeAlD
Vigabatrin—ABAT—central nervous system—multiple sclerosis	0.00795	0.0406	CbGeAlD
Vigabatrin—SLC36A1—cerebellum—multiple sclerosis	0.00782	0.0399	CbGeAlD
Vigabatrin—ABAT—cerebellum—multiple sclerosis	0.00777	0.0397	CbGeAlD
Vigabatrin—SLC36A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.00728	0.0653	CbGpPWpGaD
Vigabatrin—SLC36A1—brain—multiple sclerosis	0.00635	0.0324	CbGeAlD
Vigabatrin—ABAT—brain—multiple sclerosis	0.00631	0.0322	CbGeAlD
Vigabatrin—ABAT—Neuronal System—KCNA3—multiple sclerosis	0.00477	0.0428	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—KCNA3—multiple sclerosis	0.00406	0.0364	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00325	0.0292	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.00282	0.0253	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00247	0.0221	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—RGS1—multiple sclerosis	0.0024	0.0215	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.00208	0.0187	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CCR1—multiple sclerosis	0.00208	0.0187	CbGpPWpGaD
Vigabatrin—ABAT—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00175	0.0157	CbGpPWpGaD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00172	0.0155	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—S1PR1—multiple sclerosis	0.00171	0.0153	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00165	0.0148	CbGpPWpGaD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00149	0.0133	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00138	0.0124	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—GPR65—multiple sclerosis	0.00138	0.0124	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CCR2—multiple sclerosis	0.00134	0.012	CbGpPWpGaD
Vigabatrin—ABAT—Neuronal System—BCHE—multiple sclerosis	0.00134	0.012	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCR1—multiple sclerosis	0.00126	0.0113	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL13—multiple sclerosis	0.00126	0.0113	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00125	0.0112	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CNR1—multiple sclerosis	0.00124	0.0111	CbGpPWpGaD
Vigabatrin—GABBR1—Neuronal System—BCHE—multiple sclerosis	0.00114	0.0102	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.00111	0.00999	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00099	0.00889	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000965	0.00866	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000958	0.0086	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCL3—multiple sclerosis	0.000897	0.00805	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000876	0.00786	CbGpPWpGaD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000876	0.00786	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000863	0.00775	CbGpPWpGaD
Vigabatrin—GABBR1—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000863	0.00775	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000834	0.00748	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—RGS1—multiple sclerosis	0.00082	0.00736	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CCR2—multiple sclerosis	0.000811	0.00728	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000778	0.00698	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CNR1—multiple sclerosis	0.000749	0.00672	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—RGS1—multiple sclerosis	0.000745	0.00669	CbGpPWpGaD
Vigabatrin—Connective tissue disorder—Prednisone—multiple sclerosis	0.000735	0.00106	CcSEcCtD
Vigabatrin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000734	0.00106	CcSEcCtD
Vigabatrin—Oedema—Prednisolone—multiple sclerosis	0.000731	0.00106	CcSEcCtD
Vigabatrin—Dizziness—Azathioprine—multiple sclerosis	0.000729	0.00105	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000729	0.00105	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000726	0.00105	CcSEcCtD
Vigabatrin—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000719	0.00104	CcSEcCtD
Vigabatrin—Cough—Triamcinolone—multiple sclerosis	0.000719	0.00104	CcSEcCtD
Vigabatrin—Convulsion—Triamcinolone—multiple sclerosis	0.000714	0.00103	CcSEcCtD
Vigabatrin—Convulsion—Methylprednisolone—multiple sclerosis	0.000712	0.00103	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000711	0.00638	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000711	0.00638	CbGpPWpGaD
Vigabatrin—Urticaria—Mitoxantrone—multiple sclerosis	0.000708	0.00102	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—GPR65—multiple sclerosis	0.000706	0.00634	CbGpPWpGaD
Vigabatrin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000704	0.00102	CcSEcCtD
Vigabatrin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000704	0.00102	CcSEcCtD
Vigabatrin—Myalgia—Triamcinolone—multiple sclerosis	0.000701	0.00101	CcSEcCtD
Vigabatrin—Vomiting—Azathioprine—multiple sclerosis	0.000701	0.00101	CcSEcCtD
Vigabatrin—Pneumonia—Methotrexate—multiple sclerosis	0.0007	0.00101	CcSEcCtD
Vigabatrin—Arthralgia—Methylprednisolone—multiple sclerosis	0.0007	0.00101	CcSEcCtD
Vigabatrin—Myalgia—Methylprednisolone—multiple sclerosis	0.0007	0.00101	CcSEcCtD
Vigabatrin—Eye disorder—Prednisone—multiple sclerosis	0.000699	0.00101	CcSEcCtD
Vigabatrin—Anxiety—Methylprednisolone—multiple sclerosis	0.000697	0.00101	CcSEcCtD
Vigabatrin—Infestation—Methotrexate—multiple sclerosis	0.000696	0.00101	CcSEcCtD
Vigabatrin—Infestation NOS—Methotrexate—multiple sclerosis	0.000696	0.00101	CcSEcCtD
Vigabatrin—Drowsiness—Methotrexate—multiple sclerosis	0.000696	0.00101	CcSEcCtD
Vigabatrin—Rash—Azathioprine—multiple sclerosis	0.000695	0.001	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000695	0.001	CcSEcCtD
Vigabatrin—Dermatitis—Azathioprine—multiple sclerosis	0.000694	0.001	CcSEcCtD
Vigabatrin—Depression—Methotrexate—multiple sclerosis	0.000694	0.001	CcSEcCtD
Vigabatrin—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000693	0.001	CcSEcCtD
Vigabatrin—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000693	0.001	CcSEcCtD
Vigabatrin—Discomfort—Triamcinolone—multiple sclerosis	0.000693	0.001	CcSEcCtD
Vigabatrin—Discomfort—Methylprednisolone—multiple sclerosis	0.000691	0.000998	CcSEcCtD
Vigabatrin—Headache—Azathioprine—multiple sclerosis	0.00069	0.000997	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00069	0.000996	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—LINGO1—multiple sclerosis	0.000683	0.00613	CbGpPWpGaD
Vigabatrin—Angioedema—Dexamethasone—multiple sclerosis	0.000683	0.000986	CcSEcCtD
Vigabatrin—Angioedema—Betamethasone—multiple sclerosis	0.000683	0.000986	CcSEcCtD
Vigabatrin—Conjunctivitis—Methotrexate—multiple sclerosis	0.000677	0.000977	CcSEcCtD
Vigabatrin—Confusional state—Methylprednisolone—multiple sclerosis	0.000676	0.000977	CcSEcCtD
Vigabatrin—GABBR1—G alpha (i) signalling events—POMC—multiple sclerosis	0.000675	0.00605	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—CXCL10—multiple sclerosis	0.000674	0.00605	CbGpPWpGaD
Vigabatrin—Malaise—Dexamethasone—multiple sclerosis	0.000674	0.000973	CcSEcCtD
Vigabatrin—Malaise—Betamethasone—multiple sclerosis	0.000674	0.000973	CcSEcCtD
Vigabatrin—Oedema—Triamcinolone—multiple sclerosis	0.000672	0.000971	CcSEcCtD
Vigabatrin—Vertigo—Dexamethasone—multiple sclerosis	0.000671	0.00097	CcSEcCtD
Vigabatrin—Vertigo—Betamethasone—multiple sclerosis	0.000671	0.00097	CcSEcCtD
Vigabatrin—Infection—Triamcinolone—multiple sclerosis	0.000668	0.000964	CcSEcCtD
Vigabatrin—Infection—Methylprednisolone—multiple sclerosis	0.000666	0.000962	CcSEcCtD
Vigabatrin—Insomnia—Prednisolone—multiple sclerosis	0.000661	0.000955	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000658	0.000951	CcSEcCtD
Vigabatrin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000658	0.00095	CcSEcCtD
Vigabatrin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000656	0.000948	CcSEcCtD
Vigabatrin—Paraesthesia—Prednisolone—multiple sclerosis	0.000656	0.000948	CcSEcCtD
Vigabatrin—Mental disorder—Prednisone—multiple sclerosis	0.000655	0.000946	CcSEcCtD
Vigabatrin—Nausea—Azathioprine—multiple sclerosis	0.000655	0.000945	CcSEcCtD
Vigabatrin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000651	0.000941	CcSEcCtD
Vigabatrin—Malnutrition—Prednisone—multiple sclerosis	0.000651	0.00094	CcSEcCtD
Vigabatrin—Convulsion—Dexamethasone—multiple sclerosis	0.000648	0.000935	CcSEcCtD
Vigabatrin—Convulsion—Betamethasone—multiple sclerosis	0.000648	0.000935	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CCR1—multiple sclerosis	0.000646	0.0058	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000646	0.0058	CbGpPWpGaD
Vigabatrin—Asthenia—Mitoxantrone—multiple sclerosis	0.000639	0.000923	CcSEcCtD
Vigabatrin—Myalgia—Dexamethasone—multiple sclerosis	0.000636	0.000919	CcSEcCtD
Vigabatrin—Myalgia—Betamethasone—multiple sclerosis	0.000636	0.000919	CcSEcCtD
Vigabatrin—Anxiety—Betamethasone—multiple sclerosis	0.000634	0.000916	CcSEcCtD
Vigabatrin—Anxiety—Dexamethasone—multiple sclerosis	0.000634	0.000916	CcSEcCtD
Vigabatrin—Discomfort—Betamethasone—multiple sclerosis	0.000629	0.000908	CcSEcCtD
Vigabatrin—Discomfort—Dexamethasone—multiple sclerosis	0.000629	0.000908	CcSEcCtD
Vigabatrin—Pain—Prednisolone—multiple sclerosis	0.000625	0.000903	CcSEcCtD
Vigabatrin—SLC36A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.00062	0.00557	CbGpPWpGaD
Vigabatrin—Vision blurred—Prednisone—multiple sclerosis	0.000613	0.000886	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000612	0.000884	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000611	0.000882	CcSEcCtD
Vigabatrin—Oedema—Dexamethasone—multiple sclerosis	0.00061	0.000881	CcSEcCtD
Vigabatrin—Oedema—Betamethasone—multiple sclerosis	0.00061	0.000881	CcSEcCtD
Vigabatrin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00061	0.00088	CcSEcCtD
Vigabatrin—Insomnia—Triamcinolone—multiple sclerosis	0.000608	0.000878	CcSEcCtD
Vigabatrin—Insomnia—Methylprednisolone—multiple sclerosis	0.000607	0.000876	CcSEcCtD
Vigabatrin—Infection—Dexamethasone—multiple sclerosis	0.000606	0.000875	CcSEcCtD
Vigabatrin—Infection—Betamethasone—multiple sclerosis	0.000606	0.000875	CcSEcCtD
Vigabatrin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000604	0.000872	CcSEcCtD
Vigabatrin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000604	0.000872	CcSEcCtD
Vigabatrin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000602	0.00087	CcSEcCtD
Vigabatrin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000602	0.00087	CcSEcCtD
Vigabatrin—Visual impairment—Methotrexate—multiple sclerosis	0.000602	0.000869	CcSEcCtD
Vigabatrin—Anaemia—Prednisone—multiple sclerosis	0.000602	0.000869	CcSEcCtD
Vigabatrin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000598	0.000864	CcSEcCtD
Vigabatrin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000598	0.000864	CcSEcCtD
Vigabatrin—Agitation—Prednisone—multiple sclerosis	0.000598	0.000864	CcSEcCtD
Vigabatrin—Angioedema—Prednisone—multiple sclerosis	0.000595	0.000859	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—TAGAP—multiple sclerosis	0.000592	0.00531	CbGpPWpGaD
Vigabatrin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000592	0.000854	CcSEcCtD
Vigabatrin—Erythema multiforme—Methotrexate—multiple sclerosis	0.000591	0.000853	CcSEcCtD
Vigabatrin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00059	0.000853	CcSEcCtD
Vigabatrin—Malaise—Prednisone—multiple sclerosis	0.000587	0.000848	CcSEcCtD
Vigabatrin—Vertigo—Prednisone—multiple sclerosis	0.000585	0.000844	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—multiple sclerosis	0.000584	0.000843	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—multiple sclerosis	0.000583	0.000841	CcSEcCtD
Vigabatrin—Urticaria—Prednisolone—multiple sclerosis	0.000581	0.000839	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CCL5—multiple sclerosis	0.00058	0.00521	CbGpPWpGaD
Vigabatrin—Fatigue—Triamcinolone—multiple sclerosis	0.00058	0.000837	CcSEcCtD
Vigabatrin—Fatigue—Methylprednisolone—multiple sclerosis	0.000578	0.000835	CcSEcCtD
Vigabatrin—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000577	0.00518	CbGpPWpGaD
Vigabatrin—Pain—Triamcinolone—multiple sclerosis	0.000575	0.00083	CcSEcCtD
Vigabatrin—Vomiting—Mitoxantrone—multiple sclerosis	0.000566	0.000818	CcSEcCtD
Vigabatrin—Convulsion—Prednisone—multiple sclerosis	0.000564	0.000814	CcSEcCtD
Vigabatrin—Rash—Mitoxantrone—multiple sclerosis	0.000562	0.000811	CcSEcCtD
Vigabatrin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000561	0.00081	CcSEcCtD
Vigabatrin—Headache—Mitoxantrone—multiple sclerosis	0.000558	0.000806	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000556	0.000802	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000556	0.000802	CcSEcCtD
Vigabatrin—Arthralgia—Prednisone—multiple sclerosis	0.000554	0.0008	CcSEcCtD
Vigabatrin—Myalgia—Prednisone—multiple sclerosis	0.000554	0.0008	CcSEcCtD
Vigabatrin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000554	0.0008	CcSEcCtD
Vigabatrin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000553	0.000798	CcSEcCtD
Vigabatrin—Anxiety—Prednisone—multiple sclerosis	0.000552	0.000797	CcSEcCtD
Vigabatrin—Insomnia—Dexamethasone—multiple sclerosis	0.000552	0.000797	CcSEcCtD
Vigabatrin—Insomnia—Betamethasone—multiple sclerosis	0.000552	0.000797	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00055	0.000795	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000548	0.000792	CcSEcCtD
Vigabatrin—Paraesthesia—Betamethasone—multiple sclerosis	0.000548	0.000791	CcSEcCtD
Vigabatrin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000548	0.000791	CcSEcCtD
Vigabatrin—Discomfort—Prednisone—multiple sclerosis	0.000547	0.000791	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—multiple sclerosis	0.000547	0.00079	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—multiple sclerosis	0.000544	0.000785	CcSEcCtD
Vigabatrin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000539	0.000778	CcSEcCtD
Vigabatrin—Dyspepsia—Betamethasone—multiple sclerosis	0.000537	0.000775	CcSEcCtD
Vigabatrin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000537	0.000775	CcSEcCtD
Vigabatrin—Urticaria—Triamcinolone—multiple sclerosis	0.000534	0.000771	CcSEcCtD
Vigabatrin—Urticaria—Methylprednisolone—multiple sclerosis	0.000533	0.000769	CcSEcCtD
Vigabatrin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000531	0.000767	CcSEcCtD
Vigabatrin—Oedema—Prednisone—multiple sclerosis	0.000531	0.000767	CcSEcCtD
Vigabatrin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00053	0.000766	CcSEcCtD
Vigabatrin—Decreased appetite—Dexamethasone—multiple sclerosis	0.00053	0.000766	CcSEcCtD
Vigabatrin—Decreased appetite—Betamethasone—multiple sclerosis	0.00053	0.000766	CcSEcCtD
Vigabatrin—Nausea—Mitoxantrone—multiple sclerosis	0.000529	0.000764	CcSEcCtD
Vigabatrin—Infection—Prednisone—multiple sclerosis	0.000528	0.000762	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000527	0.00076	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000527	0.00076	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—multiple sclerosis	0.000526	0.00076	CcSEcCtD
Vigabatrin—Fatigue—Dexamethasone—multiple sclerosis	0.000526	0.000759	CcSEcCtD
Vigabatrin—Fatigue—Betamethasone—multiple sclerosis	0.000526	0.000759	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CCR5—multiple sclerosis	0.000523	0.00469	CbGpPWpGaD
Vigabatrin—Pain—Dexamethasone—multiple sclerosis	0.000522	0.000753	CcSEcCtD
Vigabatrin—Pain—Betamethasone—multiple sclerosis	0.000522	0.000753	CcSEcCtD
Vigabatrin—Nervous system disorder—Prednisone—multiple sclerosis	0.000521	0.000752	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—S1PR1—multiple sclerosis	0.000518	0.00464	CbGpPWpGaD
Vigabatrin—Skin disorder—Prednisone—multiple sclerosis	0.000516	0.000745	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—multiple sclerosis	0.000513	0.00074	CcSEcCtD
Vigabatrin—ABAT—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000511	0.00458	CbGpPWpGaD
Vigabatrin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000505	0.000729	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GPC5—multiple sclerosis	0.000504	0.00452	CbGpPWpGaD
Vigabatrin—Anaemia—Methotrexate—multiple sclerosis	0.000503	0.000726	CcSEcCtD
Vigabatrin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000503	0.000726	CcSEcCtD
Vigabatrin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000503	0.000726	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000499	0.00072	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000499	0.00072	CcSEcCtD
Vigabatrin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000495	0.000715	CcSEcCtD
Vigabatrin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000494	0.000714	CcSEcCtD
Vigabatrin—Malaise—Methotrexate—multiple sclerosis	0.00049	0.000708	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—multiple sclerosis	0.000489	0.000706	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000488	0.00438	CbGpPWpGaD
Vigabatrin—Urticaria—Betamethasone—multiple sclerosis	0.000485	0.0007	CcSEcCtD
Vigabatrin—Urticaria—Dexamethasone—multiple sclerosis	0.000485	0.0007	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000484	0.000699	CcSEcCtD
Vigabatrin—Dizziness—Prednisolone—multiple sclerosis	0.000483	0.000698	CcSEcCtD
Vigabatrin—Asthenia—Triamcinolone—multiple sclerosis	0.000482	0.000696	CcSEcCtD
Vigabatrin—Abdominal pain—Betamethasone—multiple sclerosis	0.000482	0.000696	CcSEcCtD
Vigabatrin—Body temperature increased—Betamethasone—multiple sclerosis	0.000482	0.000696	CcSEcCtD
Vigabatrin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000482	0.000696	CcSEcCtD
Vigabatrin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000482	0.000696	CcSEcCtD
Vigabatrin—Asthenia—Methylprednisolone—multiple sclerosis	0.000481	0.000695	CcSEcCtD
Vigabatrin—Insomnia—Prednisone—multiple sclerosis	0.00048	0.000694	CcSEcCtD
Vigabatrin—Paraesthesia—Prednisone—multiple sclerosis	0.000477	0.000689	CcSEcCtD
Vigabatrin—Pruritus—Triamcinolone—multiple sclerosis	0.000476	0.000687	CcSEcCtD
Vigabatrin—Cough—Methotrexate—multiple sclerosis	0.000475	0.000685	CcSEcCtD
Vigabatrin—Pruritus—Methylprednisolone—multiple sclerosis	0.000475	0.000685	CcSEcCtD
Vigabatrin—Convulsion—Methotrexate—multiple sclerosis	0.000471	0.000681	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000471	0.00423	CbGpPWpGaD
Vigabatrin—Dyspepsia—Prednisone—multiple sclerosis	0.000468	0.000675	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—multiple sclerosis	0.000463	0.000669	CcSEcCtD
Vigabatrin—Arthralgia—Methotrexate—multiple sclerosis	0.000463	0.000669	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—multiple sclerosis	0.000463	0.000669	CcSEcCtD
Vigabatrin—Decreased appetite—Prednisone—multiple sclerosis	0.000462	0.000667	CcSEcCtD
Vigabatrin—Rash—Prednisolone—multiple sclerosis	0.000461	0.000666	CcSEcCtD
Vigabatrin—Dermatitis—Prednisolone—multiple sclerosis	0.00046	0.000665	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CCL3—multiple sclerosis	0.00046	0.00413	CbGpPWpGaD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00046	0.000664	CcSEcCtD
Vigabatrin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000459	0.000663	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000458	0.00411	CbGpPWpGaD
Vigabatrin—Fatigue—Prednisone—multiple sclerosis	0.000458	0.000661	CcSEcCtD
Vigabatrin—Headache—Prednisolone—multiple sclerosis	0.000458	0.000661	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—multiple sclerosis	0.000458	0.000661	CcSEcCtD
Vigabatrin—Constipation—Prednisone—multiple sclerosis	0.000454	0.000656	CcSEcCtD
Vigabatrin—Confusional state—Methotrexate—multiple sclerosis	0.000448	0.000646	CcSEcCtD
Vigabatrin—Dizziness—Triamcinolone—multiple sclerosis	0.000445	0.000642	CcSEcCtD
Vigabatrin—Dizziness—Methylprednisolone—multiple sclerosis	0.000444	0.00064	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000443	0.00398	CbGpPWpGaD
Vigabatrin—Infection—Methotrexate—multiple sclerosis	0.000441	0.000637	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—RGS1—multiple sclerosis	0.00044	0.00395	CbGpPWpGaD
Vigabatrin—Feeling abnormal—Prednisone—multiple sclerosis	0.000438	0.000632	CcSEcCtD
Vigabatrin—Asthenia—Betamethasone—multiple sclerosis	0.000438	0.000632	CcSEcCtD
Vigabatrin—Asthenia—Dexamethasone—multiple sclerosis	0.000438	0.000632	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—multiple sclerosis	0.000435	0.000629	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000434	0.000627	CcSEcCtD
Vigabatrin—Nausea—Prednisolone—multiple sclerosis	0.000434	0.000627	CcSEcCtD
Vigabatrin—GABBR1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000434	0.0039	CbGpPWpGaD
Vigabatrin—Pruritus—Betamethasone—multiple sclerosis	0.000432	0.000623	CcSEcCtD
Vigabatrin—Pruritus—Dexamethasone—multiple sclerosis	0.000432	0.000623	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—multiple sclerosis	0.000431	0.000623	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000428	0.00384	CbGpPWpGaD
Vigabatrin—Vomiting—Triamcinolone—multiple sclerosis	0.000427	0.000617	CcSEcCtD
Vigabatrin—Vomiting—Methylprednisolone—multiple sclerosis	0.000426	0.000616	CcSEcCtD
Vigabatrin—Rash—Triamcinolone—multiple sclerosis	0.000424	0.000612	CcSEcCtD
Vigabatrin—Dermatitis—Triamcinolone—multiple sclerosis	0.000423	0.000611	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000423	0.0038	CbGpPWpGaD
Vigabatrin—Rash—Methylprednisolone—multiple sclerosis	0.000423	0.000611	CcSEcCtD
Vigabatrin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000422	0.00061	CcSEcCtD
Vigabatrin—Urticaria—Prednisone—multiple sclerosis	0.000422	0.000609	CcSEcCtD
Vigabatrin—Headache—Triamcinolone—multiple sclerosis	0.000421	0.000608	CcSEcCtD
Vigabatrin—Headache—Methylprednisolone—multiple sclerosis	0.00042	0.000607	CcSEcCtD
Vigabatrin—Body temperature increased—Prednisone—multiple sclerosis	0.00042	0.000606	CcSEcCtD
Vigabatrin—Abdominal pain—Prednisone—multiple sclerosis	0.00042	0.000606	CcSEcCtD
Vigabatrin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000417	0.000603	CcSEcCtD
Vigabatrin—Diarrhoea—Betamethasone—multiple sclerosis	0.000417	0.000603	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—GPR65—multiple sclerosis	0.000417	0.00374	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCR2—multiple sclerosis	0.000416	0.00374	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR ligand binding—POMC—multiple sclerosis	0.000409	0.00367	CbGpPWpGaD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000404	0.000584	CcSEcCtD
Vigabatrin—Dizziness—Dexamethasone—multiple sclerosis	0.000403	0.000582	CcSEcCtD
Vigabatrin—Dizziness—Betamethasone—multiple sclerosis	0.000403	0.000582	CcSEcCtD
Vigabatrin—Insomnia—Methotrexate—multiple sclerosis	0.000401	0.00058	CcSEcCtD
Vigabatrin—GABBR1—GPCR ligand binding—CCL2—multiple sclerosis	0.0004	0.00359	CbGpPWpGaD
Vigabatrin—Nausea—Triamcinolone—multiple sclerosis	0.000399	0.000577	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—multiple sclerosis	0.000399	0.000576	CcSEcCtD
Vigabatrin—Nausea—Methylprednisolone—multiple sclerosis	0.000398	0.000575	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—multiple sclerosis	0.000395	0.00057	CcSEcCtD
Vigabatrin—Hypersensitivity—Prednisone—multiple sclerosis	0.000391	0.000565	CcSEcCtD
Vigabatrin—ABAT—Neuronal System—MAPK1—multiple sclerosis	0.000391	0.00351	CbGpPWpGaD
Vigabatrin—Dyspepsia—Methotrexate—multiple sclerosis	0.000391	0.000564	CcSEcCtD
Vigabatrin—Vomiting—Betamethasone—multiple sclerosis	0.000388	0.00056	CcSEcCtD
Vigabatrin—Vomiting—Dexamethasone—multiple sclerosis	0.000388	0.00056	CcSEcCtD
Vigabatrin—Decreased appetite—Methotrexate—multiple sclerosis	0.000386	0.000557	CcSEcCtD
Vigabatrin—Rash—Betamethasone—multiple sclerosis	0.000385	0.000555	CcSEcCtD
Vigabatrin—Rash—Dexamethasone—multiple sclerosis	0.000385	0.000555	CcSEcCtD
Vigabatrin—Dermatitis—Dexamethasone—multiple sclerosis	0.000384	0.000555	CcSEcCtD
Vigabatrin—Dermatitis—Betamethasone—multiple sclerosis	0.000384	0.000555	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CNR1—multiple sclerosis	0.000384	0.00345	CbGpPWpGaD
Vigabatrin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000383	0.000553	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—multiple sclerosis	0.000383	0.000553	CcSEcCtD
Vigabatrin—Headache—Dexamethasone—multiple sclerosis	0.000382	0.000552	CcSEcCtD
Vigabatrin—Headache—Betamethasone—multiple sclerosis	0.000382	0.000552	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CCR1—multiple sclerosis	0.000382	0.00342	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL13—multiple sclerosis	0.000382	0.00342	CbGpPWpGaD
Vigabatrin—Asthenia—Prednisone—multiple sclerosis	0.000381	0.00055	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000381	0.00342	CbGpPWpGaD
Vigabatrin—Pain—Methotrexate—multiple sclerosis	0.00038	0.000548	CcSEcCtD
Vigabatrin—Pruritus—Prednisone—multiple sclerosis	0.000376	0.000543	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000366	0.000528	CcSEcCtD
Vigabatrin—Diarrhoea—Prednisone—multiple sclerosis	0.000363	0.000525	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000363	0.000524	CcSEcCtD
Vigabatrin—Nausea—Betamethasone—multiple sclerosis	0.000362	0.000523	CcSEcCtD
Vigabatrin—Nausea—Dexamethasone—multiple sclerosis	0.000362	0.000523	CcSEcCtD
Vigabatrin—Urticaria—Methotrexate—multiple sclerosis	0.000353	0.000509	CcSEcCtD
Vigabatrin—Dizziness—Prednisone—multiple sclerosis	0.000351	0.000507	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—multiple sclerosis	0.000351	0.000507	CcSEcCtD
Vigabatrin—Body temperature increased—Methotrexate—multiple sclerosis	0.000351	0.000507	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000346	0.0031	CbGpPWpGaD
Vigabatrin—Vomiting—Prednisone—multiple sclerosis	0.000338	0.000488	CcSEcCtD
Vigabatrin—Rash—Prednisone—multiple sclerosis	0.000335	0.000484	CcSEcCtD
Vigabatrin—Dermatitis—Prednisone—multiple sclerosis	0.000335	0.000483	CcSEcCtD
Vigabatrin—Headache—Prednisone—multiple sclerosis	0.000333	0.000481	CcSEcCtD
Vigabatrin—GABBR1—Neuronal System—MAPK1—multiple sclerosis	0.000333	0.00298	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000328	0.00294	CbGpPWpGaD
Vigabatrin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000327	0.000472	CcSEcCtD
Vigabatrin—Asthenia—Methotrexate—multiple sclerosis	0.000318	0.00046	CcSEcCtD
Vigabatrin—Nausea—Prednisone—multiple sclerosis	0.000316	0.000456	CcSEcCtD
Vigabatrin—SLC36A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000315	0.00283	CbGpPWpGaD
Vigabatrin—Pruritus—Methotrexate—multiple sclerosis	0.000314	0.000454	CcSEcCtD
Vigabatrin—Diarrhoea—Methotrexate—multiple sclerosis	0.000304	0.000439	CcSEcCtD
Vigabatrin—GABBR1—Signaling by GPCR—CCL5—multiple sclerosis	0.000298	0.00267	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000295	0.00265	CbGpPWpGaD
Vigabatrin—Dizziness—Methotrexate—multiple sclerosis	0.000294	0.000424	CcSEcCtD
Vigabatrin—GABBR1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000291	0.00261	CbGpPWpGaD
Vigabatrin—Vomiting—Methotrexate—multiple sclerosis	0.000282	0.000408	CcSEcCtD
Vigabatrin—Rash—Methotrexate—multiple sclerosis	0.00028	0.000404	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—multiple sclerosis	0.00028	0.000404	CcSEcCtD
Vigabatrin—Headache—Methotrexate—multiple sclerosis	0.000278	0.000402	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—CCL3—multiple sclerosis	0.000272	0.00244	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCR5—multiple sclerosis	0.000268	0.00241	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000264	0.00237	CbGpPWpGaD
Vigabatrin—Nausea—Methotrexate—multiple sclerosis	0.000264	0.000381	CcSEcCtD
Vigabatrin—GABBR1—Signaling Pathways—PTGER4—multiple sclerosis	0.000262	0.00235	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—PGR—multiple sclerosis	0.000258	0.00231	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCR3—multiple sclerosis	0.000253	0.00227	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CD28—multiple sclerosis	0.00025	0.00225	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCR2—multiple sclerosis	0.000246	0.00221	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—POMC—multiple sclerosis	0.000231	0.00207	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CNR1—multiple sclerosis	0.000227	0.00204	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—POMC—multiple sclerosis	0.00021	0.00188	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—CCL2—multiple sclerosis	0.000205	0.00184	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CXCL10—multiple sclerosis	0.000204	0.00183	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—TYK2—multiple sclerosis	0.000186	0.00167	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CD86—multiple sclerosis	0.000179	0.0016	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL5—multiple sclerosis	0.000176	0.00158	CbGpPWpGaD
Vigabatrin—GABBR1—GPCR downstream signaling—IL2—multiple sclerosis	0.000171	0.00153	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—SPP1—multiple sclerosis	0.000163	0.00146	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCR5—multiple sclerosis	0.000158	0.00142	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL2RA—multiple sclerosis	0.000156	0.0014	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL2—multiple sclerosis	0.000155	0.00139	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—APOE—multiple sclerosis	0.000144	0.00129	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CD80—multiple sclerosis	0.00013	0.00117	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—POMC—multiple sclerosis	0.000124	0.00111	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—CCL2—multiple sclerosis	0.000121	0.00109	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000119	0.00106	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TYK2—multiple sclerosis	0.00011	0.000987	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL2—multiple sclerosis	9.16e-05	0.000822	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling by GPCR—IL6—multiple sclerosis	9.11e-05	0.000817	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MMP9—multiple sclerosis	8.67e-05	0.000778	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—STAT3—multiple sclerosis	7.7e-05	0.000691	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MYC—multiple sclerosis	7.16e-05	0.000642	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—TGFB1—multiple sclerosis	7.14e-05	0.000641	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—MAPK1—multiple sclerosis	7e-05	0.000628	CbGpPWpGaD
Vigabatrin—GABBR1—Signaling Pathways—IL6—multiple sclerosis	5.38e-05	0.000483	CbGpPWpGaD
